The researchers created a highly effective conversion technique using mouse cells that can generate over ten neurons from a single skin cell.
Bioreactors are specialized containers that allow the controlled development of cells, enzymes, or microbes. Environmental engineering, biotechnology, and pharmaceuticals are just a few of the disciplines in which they are essential. What is a Bioreactor? A bioreactor is an equipment or container that offers a regulated setting for biological processes […]
The researchers found that the tumor was produced by more than only the T cells’ present genetic changes.
The first medication approved by the FDA to treat CTX, a rare lipid storage condition, is Ctexli.
Utilizing reduced Takumi-shaped DNA nanostructures, researchers create optimal DNA hydrogels with possible biological uses.
Rare yet debilitating disorders, Dravet syndrome, and other developing epileptic encephalopathies induce a variety of symptoms in children, such as seizures, intellectual incapacity, and even unexpected death. The majority of cases are brought on by a genetic mutation; variations in the sodium channel gene SCN1A are most frequently the cause […]
The U.S. Food and Drug Administration (FDA) has approved GOMEKLI™ (mirdametinib), SpringWorks Therapeutics, Inc.’s MEK inhibitor, for the treatment of adult and pediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic plexiform neurofibromas (PN) that are not amenable to complete resection. SpringWorks Therapeutics, Inc. is a commercial-stage biopharmaceutical company […]
The production of energy that powers cells and facilitates their operation depends on mitochondria. On the other hand, disorders like type 2 diabetes are linked to mitochondrial abnormalities. Individuals with this condition are unable to use the insulin their pancreas produces to maintain normal blood sugar levels or create enough […]
Surgery to remove the tumor is the standard of care for individuals with stage III or IV clear cell renal cell carcinoma.
In preclinical models tested in mice, a possible novel targeted therapy for children brain cancer has been found to be successful in infiltrating and destroying tumor cells
